Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TRDATRDA
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ENTRADA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 177,343 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $1.3M as of 2026-Q2. The position was decreased (-16.6% shares). TRDA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.3M

Current Shares

177,343

Total Value Change

-$44,523

Total Shares Change

+92,877

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
177,343
-16.6%
$1.3M0.0%$7.36
0
2026-Q1
Increased
212,780
+3.7%
$2.7M0.0%$11.85
27
2025-Q4
Decreased
205,173
-7.7%
$2.1M0.0%$10.09
0
2025-Q3
Increased
222,336
+164.2%
$1.3M0.0%$5.84
41
2025-Q2
Decreased
84,150
-9.1%
$565,4900.0%$6.91
0
2025-Q1
Decreased
92,540
-67.6%
$836,5640.0%$9.56
0
2024-Q4
Increased
285,272
+237.7%
$4.9M0.0%$17.37
43
2024-Q3
Increased
84,466
+153.6%
$1.3M0.0%$16.45
41

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used